Biotech Values

[rfj1862]

MRKR

Just listened to the Webex they had this morning on the pancreatic data. Surprised by the 30% drop in response to what I consider wildly positive (albeit limited) data in pancreatic cancer. Even if the data were negative, which they are not, pancreatic is just an early-stage side show.

Talk about inefficient markets!

Also Lumpy if you read this--I won't post on the other board because one of the moderators is horribly misinformed about even the basics of biotech and keeps deleting my posts and others when they contradict his misinformation.